000 01173 a2200313 4500
005 20250516074009.0
264 0 _c20120313
008 201203s 0 0 eng d
022 _a1462-0332
024 7 _a10.1093/rheumatology/ker363
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVerstappen, Suzanne M M
245 0 0 _aMethodological issues when measuring paid productivity loss in patients with arthritis using biologic therapies: an overview of the literature.
_h[electronic resource]
260 _bRheumatology (Oxford, England)
_cFeb 2012
300 _a216-29 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aArthritis
_xeconomics
650 0 4 _aBiological Products
_xtherapeutic use
650 0 4 _aEfficiency
650 0 4 _aEmployment
_xeconomics
650 0 4 _aEpidemiologic Research Design
650 0 4 _aHumans
700 1 _aFautrel, Bruno
700 1 _aDadoun, Sabrina
700 1 _aSymmons, Deborah P M
700 1 _aBoonen, Annelies
773 0 _tRheumatology (Oxford, England)
_gvol. 51
_gno. 2
_gp. 216-29
856 4 0 _uhttps://doi.org/10.1093/rheumatology/ker363
_zAvailable from publisher's website
999 _c21482006
_d21482006